ShawJE, SicreeRA, ZimmetPZ.Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010; 87:4–14.
3.
International Diabetes Federation. IDF Diabetes Atlas, 6th edition. Brussels, Belgium: International Diabetes Federation, 2013:52–126.
4.
NarayanKM, BoyleJP, GeissLS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care, 2006; 29:2114–2116.
5.
NehraA.Erectile dysfunction and cardiovascular disease: Efficacy and safety of Phosphodiesterase Type 5 inhibitors in men with both conditions. Mayo Clin Proc, 2009; 84:139–148.
6.
HajjarI, KotchenTA.Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA, 2003; 290:199–206.
7.
ChobanianAV, BakrisGL, BlackHR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 2003; 42:1206–1252.
8.
NehraA, JacksonG, MinerM, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc, 2012; 87:766–778.